The Symptoms Prevalence,Medical Interventions,and Health Care Service Needs for Patients With End-Stage Renal Disease in a Renal Palliative Care Program
Restricted accessResearch articleFirst published online December, 2016
The Symptoms Prevalence,Medical Interventions,and Health Care Service Needs for Patients With End-Stage Renal Disease in a Renal Palliative Care Program
A retrospective study was conducted to evaluate the symptoms prevalence and interventions initiated in the last 2 weeks of life, health care service utilization, and causes of death of patients with end-stage renal disease (ESRD under a renal palliative care (RPC) program. A total of 335 RPC patients were included, of which 226 patients died during the study period. The 5 most prevalent symptoms were dyspnea (63.7%), fatigue (51.8%), edema (48.2%), pain (44.2%), and anorexia (38.1%); and the 5 most prevalent interventions initiated were oxygen (69.5%), parenteral infusion (67.3%), antibiotics (53.5%), bladder catheterization (44.7%), and analgesic (39.8%) in the last 2 weeks of life. Each patient received 3.5 ± 4.4 outpatient clinic visit, 3.4 ± 10.3 home care visits, and 3.1 ± 2.7 hospital admissions. Besides ESRD (51.8%), the most common causes of death were cardiovascular events (18.6%) and infection (17.2%).
U.S. Renal Data System, USRDS 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2014. United States Renal Data System, Web site. http://www.usrds.org/adr.htm. 2014, Published November 2014. Accessed June 19, 2015.
2.
CanaudBTongLTentoriF. Clinical practices and outcomes in elderly hemodialysis patients: Results from the dialysis outcomes and practice patterns study (DOPPS). Clin J Am Soc Nephrol. 2011;6(7):1651–1662.
3.
UK Renal Registry Report 2014, Web site. http://www.renalreg.org. 2014, Published December 2014. Accessed June 19, 2015.
4.
SteenkampRRaoARoderickP. UK Renal Registry 17th Annual Report: Chapter 5. Survival and Causes of Death in UK Adult Patients on Renal Replacement Therapy in 2013: National and Centre-Specific Analyses. Nephron. 2015;129(suppl 1):99–129. doi:10.1159/00370275.
5.
MerkusMPJagerKJDekkerFW. Physical symptoms and quality of life in patients on chronic dialysis: result of The Netherlands Cooperative Study on Adequacy of Dialysis (NECOSAD). Nephrol Dial Transplant. 1999;14(5):1163–1170.
6.
WeisbordSDCarmodySSBurnsFJ. Symptom burden, quality of life, advance care planning and the potential value of palliative care in severely ill haemodialysis patients. Nephrol Dial Transplant. 2003;18(7):1345–1352.
7.
MurtaghFECohenLMGermainMJ. The “no dialysis” option. Adv Chronic Kidney Dis. 2011;18(6):443–449.
8.
RockvilleMD. Shared decision-making in the appropriate initiation of and withdrawal from dialysis. The Renal Physicians Association, 2010, Web site. www.renalmd.org. 2010, Published October 2010. Accessed June 19, 2015.
9.
Planning, initiating, and withdrawal of renal replacement therapy. United Kingdom: UK Renal Association, 2009, Web site. www.renal.org. 2009, Accessed June 19, 2013.
10.
LiPKChowKM. Peritoneal dialysis-first policy made successful: perspectives and actions. Am J Kidney Dis. 2013;62(5):993–1005.
11.
HoYWChauKFChoyBY. Hong Kong Renal Registry Report 2012. Hong Kong J Nephrol. 2013;15(1):28–43.
12.
TseMW. Experience of a Renal Palliative Care Program in a Hong Kong center: characteristics of patients who prefer palliative care to dialysis. Hong Kong J Nephrol. 2009;11(2):50–58.
13.
BeddhuSBrunFJSaulMSeddonPZeidelML. A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. Am J Med. 2000;108(8):609–613.
UrbanAKBrennanF. Patients who withdraw from dialysis in a Sydney centre with palliative care support: who, why, and how do our patients die?Prog Palliat Care. 2013;21(6):325–330.
16.
WangAWMLamCWKChanIHS. Sudden cardiac death in end-stage renal disease patients a 5-year prospective analysis. Hypertension. 2015;56(2):210–216.
17.
ChowKMSzetoCCKwanBCH. Factors associated with sudden death in peritoneal dialysis patients. Perit Dial Int. 2009;29(1):58–63.
18.
GermainMJCohenLMDavisonSN. Withholding and withdrawing from dialysis: what we know about how our patients die. Semin Dial. 2007;20(3):200–204.
19.
ChaterSDavisonSNGermainMJCohenLM. Withdrawal from dialysis: a palliative care perspective. Clin Nephrol. 2006;66(5):364–372.
20.
YongSPKwokOLWongDSuenMHChenWTTseDM. Symptom burden and quality of life in end-stage renal disease: a study of 179 patients on dialysis and palliative care. Palliat Med. 2009;23(2):111–119.
21.
O’ConnorNRKumarP. Conservative management of end-stage renal disease without dialysis: a systematic review. J Palliat Med. 2012;15(2):228–235.
22.
MurtaghFEAddington-HallJEdmondsP. Symptoms in the month before death for stage 5 chronic kidney disease patients managed without dialysis. J Pain Symptom Manage. 2010;40(3):342–352.
23.
MutaghFESheerinNSAddington-HallJHigginsonIJ. Trajectories of illness in stage 5 chronic kidney disease: A longitudinal study of patient symptoms and concerns in the last year of life. Clin J Am Soc Nephrol. 2011;6(7):1580–1590.
24.
LauKSTseDMWChenTWT. Comparing Noncancer and Cancer deaths in Hong Kong: A Retrospective Review. J Pain Symptom Manage. 2010;40(5):704–714.
25.
SzetoCCKwanBCHChowKM. Life expectancy of Chinese patients with chronic kidney disease without dialysis. Nephrology. 2011;16(7):715–719.
26.
LunneyJRLynnJFoleyDJ. Patterns of functional decline at the end of life. JAMA. 2003;289(18):2387–2392.
27.
TenoJMWeitzenSFennellML. Dying Trajectory in the last year of life: does cancer trajectory fit other diseases?J Palliat Med. 2001;4(4):457–464.
28.
MurraySAKendallMBoydK. Illness trajectories and palliative care. BMJ. 2005;330(7498):1007–1011.
